Indian Lenalidomide Exporters: Complete Supplier Ranking with Market Share — 237 Manufacturers (2026) — TransData Nexus

Q: Who is the largest lenalidomide supplier from India?

SUN PHARMACEUTICAL INDUSTRIES LIMITED is the largest lenalidomide exporter from India with a 54.5% market share and export value of $481.0M.

Q: How many lenalidomide suppliers are there in India?

There are 237 active lenalidomide exporters in India, collectively shipping $883.1M worth of lenalidomide across 2,724 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top lenalidomide suppliers from India?

The top 5 lenalidomide suppliers from India — SUN PHARMACEUTICAL INDUSTRIES LIMITED, EUGIA PHARMA SPECIALITIES LIMITED, DR REDDYS LABORATORIES LIMITED, CIPLA LIMITED, RELIANCE LIFE SCIENCES PRIVATE LIMITED — together control 98.9% of total lenalidomide export value from India.

Suresh Sormare

Lenalidomide

India Pharmaceutical Trade Intelligence

$883.1M237 Suppliers122 CountriesHS 30049049

ExportsIndia → UNITED STATES96.7%India → JAPAN0.6%

ImportsUNITED STATES → India$1.6M SWITZERLAND → India$1.3M

#1 Supplier: SUN PHARMACEUTICAL #1 Buyer: SUN PHARMACEUTICAL

Lenalidomide Suppliers from India (2026) — 237 Exporters, $883.1M Market | TransData Nexus | TransData Nexus

Who Exports Lenalidomide from India — 237 Suppliers Behind a $883.1M Market

India's lenalidomide export market is supplied by 237 active exporters who collectively shipped $883.1M across 2,724 shipments. SUN PHARMACEUTICAL INDUSTRIES LIMITED leads with a 54.5% market share, followed by EUGIA PHARMA SPECIALITIES LIMITED and DR REDDYS LABORATORIES LIMITED. The top 5 suppliers together control 98.9% of total export value, reflecting a concentrated market structure.

Source: Indian Customs (DGFT)·Published March 2026

India's Top Lenalidomide Suppliers & Exporters — 237 manufacturers, $883.1M export market, top destinations and formulations — Lenalidomide supplier data — 237 exporters · $883.1M market · 2,724 shipmentsTransData Nexus · Indian Customs Data

Top Lenalidomide Exporters from India — Ranked by Export Value

SUN PHARMACEUTICAL INDUSTRIES LIMITED is the leading lenalidomide exporter from India, holding a 54.5% share of the $883.1M market across 2,724 shipments from 237 exporters. The top 5 suppliers — SUN PHARMACEUTICAL INDUSTRIES LIMITED, EUGIA PHARMA SPECIALITIES LIMITED, DR REDDYS LABORATORIES LIMITED, CIPLA LIMITED, RELIANCE LIFE SCIENCES PRIVATE LIMITED — collectively control 98.9% of total export value, indicating a highly concentrated market. Individual shares are: SUN PHARMACEUTICAL INDUSTRIES LIMITED (54.5%), EUGIA PHARMA SPECIALITIES LIMITED (19.5%), DR REDDYS LABORATORIES LIMITED (14.8%), CIPLA LIMITED (9.3%), RELIANCE LIFE SCIENCES PRIVATE LIMITED (0.9%).

Top Lenalidomide Exporters from India

Ranked by export value · 237 active suppliers · Indian Customs (DGFT) data

Mar 2026

Top Lenalidomide Exporters from India — Ranked by Export Value. 237 active suppliers with export value, shipments, countries and formulations data compiled from Indian Customs records by TransData Nexus.
#	Supplier & Formulations	Value	Ships.	Ctry.	Share
1

Supplier Certification & Compliance Matrix

FDA, WHO-GMP, and EU GMP status for top Lenalidomide exporters

Certification and compliance status for top Lenalidomide suppliers from India
Supplier	US FDA	WHO-GMP	EU GMP	ANDAs	Notes
Sun Pharmaceutical Industries Limited	Approved	Yes	Yes	Multiple	Received US FDA approval for generic Lenalidomide Capsules in February 2023.
Dr. Reddy's Laboratories Limited	Approved	Yes	Yes	Multiple	Manufactures and markets a wide range of pharmaceuticals in India and overseas.
Cipla Limited	Approved	Yes	Yes	Multiple	Develops medications for various medical conditions and is the third-largest dru
Natco Pharma Limited	Approved	Yes	Yes	Multiple	Approved under India's PLI Scheme for Pharmaceuticals as of May 2023.
Mylan Laboratories Limited	Approved	Yes	Yes	Multiple	Approved under India's PLI Scheme for Pharmaceuticals as of May 2023.
Intas Pharmaceuticals Limited	Approved	Yes	Yes	Multiple	Approved under India's PLI Scheme for Pharmaceuticals as of May 2023.
Lupin Limited	Approved	Yes	Yes	Multiple	Approved under India's PLI Scheme for Pharmaceuticals as of May 2023.
Aurobindo Pharma Limited	Approved	Yes	Yes	Multiple	Approved under India's PLI Scheme for Pharmaceuticals as of May 2023.
Cadila Healthcare Limited	Approved	Yes	Yes	Multiple	Approved under India's PLI Scheme for Pharmaceuticals as of May 2023.

TransData Nexus reviewed the regulatory standing of 9 leading Lenalidomide exporters from India. 9 hold US FDA facility approvals, 9 maintain WHO-GMP certification, and 9 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.

Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.

TransData Nexus Research · Mar 2026

Manufacturing Hub Analysis — Vendor Proximity

India's pharmaceutical clusters relevant to Lenalidomide sourcing

1Hyderabad — Bulk Drug Capital

Hyderabad, often referred to as the "Bulk Drug Capital of India," is a pivotal hub for pharmaceutical manufacturing. The city hosts Genome Valley, India's first biotech cluster, and is home to over 800 pharmaceutical companies, including major players like Dr. Reddy’s Laboratories and Aurobindo Pharma. This concentration of industry is supported by advanced R&D infrastructure and a skilled talent pool from institutions such as the National Institute of Pharmaceutical Education and Research (NIPER) and the Indian Institute of Chemical Technology (IICT).

Hyderabad's specialization in Active Pharmaceutical Ingredients (APIs), vaccines, biologics, and biosimilars positions it as a key player in the production of complex drugs like Lenalidomide. The Telangana government's initiative to develop "Pharma City," poised to be the world's largest integrated pharma cluster, further underscores the region's commitment to pharmaceutical excellence.

2Ahmedabad-Vadodara — Formulations Hub

The Ahmedabad-Vadodara corridor in Gujarat is renowned for its robust pharmaceutical manufacturing capabilities. Gujarat contributes nearly 28% of India's pharmaceutical production and is home to a mature pharma ecosystem. Major companies such as Zydus Lifesciences, Intas Pharmaceuticals, Torrent Pharmaceuticals, and Cadila Pharmaceuticals are headquartered here.

This region's strong support infrastructure, including ports, roads, power, and water, facilitates efficient production and export of pharmaceutical formulations. The presence of these industry leaders indicates a significant capacity for manufacturing and exporting drugs like Lenalidomide.

Recent M&A, Collaborations & Capacity Expansions

Industry developments among top Lenalidomide exporters from India

January 2024

M&A

Sun Pharmaceutical Industries Limited — Sun Pharma acquires remaining stake in Taro Pharmaceuticals for $347.73 million

Sun Pharma entered into a definitive merger agreement to acquire the remaining stake in Taro Pharmaceuticals for $347.73 million. - IMPACT: This acquisition is expected to enhance Sun Pharma's product portfolio and manufacturing capabilities, potentially increasing Lenalidomide production and exports.

Impact: This acquisition is expected to enhance Sun Pharma's product portfolio and manufacturing capabilities, potentially increasing Lenalidomide production and exports.

March 2025

M&A

Sun Pharmaceutical Industries Limited — Sun Pharma acquires Checkpoint Therapeutics for $355 million

Sun Pharma acquired Checkpoint Therapeutics, a company specializing in immunotherapy and targeted oncology treatments, for $355 million. - IMPACT: This acquisition may bolster Sun Pharma's oncology portfolio, potentially leading to increased Lenalidomide production and exports.

Impact: This acquisition may bolster Sun Pharma's oncology portfolio, potentially leading to increased Lenalidomide production and exports.

Common Questions — Lenalidomide Suppliers from India

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

Q Which lenalidomide supplier from India is the most reliable for bulk orders?

Based on shipment frequency and export consistency, SUN PHARMACEUTICAL INDUSTRIES LIMITED leads with 144 recorded shipments worth $481.0M. EUGIA PHARMA SPECIALITIES LIMITED (189 shipments) and DR REDDYS LABORATORIES LIMITED (4 shipments) are also established high-volume exporters.

Q How many lenalidomide manufacturers are there in India?

India has 237 active lenalidomide exporters with a combined export market of $883.1M across 2,724 shipments to 122 countries. The top 5 suppliers hold 98.9% of total export value.

Q What certifications should I verify?

Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).

Q What is the typical price range for lenalidomide from India?

Average FOB unit price: $134.82 per unit, ranging from $0.01 to $12274.09. Average shipment value: .

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Lenalidomide

Lenalidomide

Who Exports Lenalidomide from India — 237 Suppliers Behind a $883.1M Market

Top Lenalidomide Exporters from India — Ranked by Export Value

Top Lenalidomide Exporters from India

Related Analysis

Need Details?

Supplier Certification & Compliance Matrix

Manufacturing Hub Analysis — Vendor Proximity

1Hyderabad — Bulk Drug Capital

2Ahmedabad-Vadodara — Formulations Hub

Recent M&A, Collaborations & Capacity Expansions

Sun Pharmaceutical Industries Limited — Sun Pharma acquires remaining stake in Taro Pharmaceuticals for $347.73 million

Sun Pharmaceutical Industries Limited — Sun Pharma acquires Checkpoint Therapeutics for $355 million

Common Questions — Lenalidomide Suppliers from India

Q Which lenalidomide supplier from India is the most reliable for bulk orders?

Q How many lenalidomide manufacturers are there in India?

Q What certifications should I verify?

Q What is the typical price range for lenalidomide from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

3Mumbai-Thane-Raigad — Export Gateway

4Baddi-Nalagarh — Tax Incentive Zone

5Sourcing Recommendations

Dr. Reddy's Laboratories Limited — Dr. Reddy's acquires Haleon Plc.'s global nicotine replacement therapy brands for £500 million

Dr. Reddy's Laboratories Limited — Bain Capital approaches Dr. Reddy's for joint bid to acquire Cipla

Sun Pharmaceutical Industries Limited — Sun Pharma acquires U.S.-based immuno-oncology company Checkpoint Therapeutics for $355 million

Analysis Methodology